161 related articles for article (PubMed ID: 30413755)
1. CCAAT/Enhancer Binding Protein β inhibits myogenic differentiation via ID3.
AlSudais H; Lala-Tabbert N; Wiper-Bergeron N
Sci Rep; 2018 Nov; 8(1):16613. PubMed ID: 30413755
[TBL] [Abstract][Full Text] [Related]
2. Mdm2 promotes myogenesis through the ubiquitination and degradation of CCAAT/enhancer-binding protein β.
Fu D; Lala-Tabbert N; Lee H; Wiper-Bergeron N
J Biol Chem; 2015 Apr; 290(16):10200-7. PubMed ID: 25720496
[TBL] [Abstract][Full Text] [Related]
3. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia.
Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N
PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein beta is expressed in satellite cells and controls myogenesis.
Marchildon F; Lala N; Li G; St-Louis C; Lamothe D; Keller C; Wiper-Bergeron N
Stem Cells; 2012 Dec; 30(12):2619-30. PubMed ID: 23034923
[TBL] [Abstract][Full Text] [Related]
5. From quiescence to repair: C/EBPβ as a regulator of muscle stem cell function in health and disease.
AlSudais H; Wiper-Bergeron N
FEBS J; 2022 Nov; 289(21):6518-6530. PubMed ID: 34854237
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexia.
Marchildon F; Fu D; Lala-Tabbert N; Wiper-Bergeron N
Cell Death Dis; 2016 Feb; 7(2):e2109. PubMed ID: 26913600
[TBL] [Abstract][Full Text] [Related]
7. Ankyrin repeat domain protein 2 and inhibitor of DNA binding 3 cooperatively inhibit myoblast differentiation by physical interaction.
Mohamed JS; Lopez MA; Cox GA; Boriek AM
J Biol Chem; 2013 Aug; 288(34):24560-8. PubMed ID: 23824195
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer binding protein β is required for satellite cell self-renewal.
Lala-Tabbert N; AlSudais H; Marchildon F; Fu D; Wiper-Bergeron N
Skelet Muscle; 2016 Dec; 6(1):40. PubMed ID: 27923399
[TBL] [Abstract][Full Text] [Related]
9. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
10. Muscle cell differentiation is inhibited by the helix-loop-helix protein Id3.
Melnikova IN; Christy BA
Cell Growth Differ; 1996 Aug; 7(8):1067-79. PubMed ID: 8853903
[TBL] [Abstract][Full Text] [Related]
11. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
[TBL] [Abstract][Full Text] [Related]
12. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
13. The Expression of Porcine Prdx6 Gene Is Up-Regulated by C/EBPβ and CREB.
Wu X; Ji P; Zhang L; Bu G; Gu H; Wang X; Xiong Y; Zuo B
PLoS One; 2015; 10(12):e0144851. PubMed ID: 26659441
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel MyoD gene targets in proliferating myogenic stem cells.
Wyzykowski JC; Winata TI; Mitin N; Taparowsky EJ; Konieczny SF
Mol Cell Biol; 2002 Sep; 22(17):6199-208. PubMed ID: 12167713
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid promotes myogenesis in myoblasts by antagonizing transforming growth factor-beta signaling via C/EBPβ.
Lamarche É; Lala-Tabbert N; Gunanayagam A; St-Louis C; Wiper-Bergeron N
Skelet Muscle; 2015; 5():8. PubMed ID: 25878769
[TBL] [Abstract][Full Text] [Related]
16. Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice.
Kassar-Duchossoy L; Gayraud-Morel B; Gomès D; Rocancourt D; Buckingham M; Shinin V; Tajbakhsh S
Nature; 2004 Sep; 431(7007):466-71. PubMed ID: 15386014
[TBL] [Abstract][Full Text] [Related]
17. Dll4 and PDGF-BB convert committed skeletal myoblasts to pericytes without erasing their myogenic memory.
Cappellari O; Benedetti S; Innocenzi A; Tedesco FS; Moreno-Fortuny A; Ugarte G; Lampugnani MG; Messina G; Cossu G
Dev Cell; 2013 Mar; 24(6):586-99. PubMed ID: 23477786
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of muscle-specific gene expression by Id3: requirement of the C-terminal region of the protein for stable expression and function.
Chen B; Han BH; Sun XH; Lim RW
Nucleic Acids Res; 1997 Jan; 25(2):423-30. PubMed ID: 9016574
[TBL] [Abstract][Full Text] [Related]
19. Ascl2 inhibits myogenesis by antagonizing the transcriptional activity of myogenic regulatory factors.
Wang C; Wang M; Arrington J; Shan T; Yue F; Nie Y; Tao WA; Kuang S
Development; 2017 Jan; 144(2):235-247. PubMed ID: 27993983
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation analysis of human myoblasts during in vitro myogenic differentiation: de novo methylation of promoters of muscle-related genes and its involvement in transcriptional down-regulation.
Miyata K; Miyata T; Nakabayashi K; Okamura K; Naito M; Kawai T; Takada S; Kato K; Miyamoto S; Hata K; Asahara H
Hum Mol Genet; 2015 Jan; 24(2):410-23. PubMed ID: 25190712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
